UiPath (NYSE:PATH) Trading Down 0.4%

UiPath Inc. (NYSE:PATH)’s stock price was down 0.4% during mid-day trading on Thursday . The company traded as low as $18.88 and last traded at $19.17. Approximately 1,064,808 shares were traded during mid-day trading, a decline of 87% from the average daily volume of 8,476,149 shares. The stock had previously closed at $19.24.

Analyst Ratings Changes

A number of analysts have issued reports on PATH shares. Barclays raised their price target on UiPath from $23.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Friday, March 15th. Needham & Company LLC restated a “buy” rating and issued a $30.00 price objective on shares of UiPath in a report on Wednesday, March 20th. Truist Financial restated a “buy” rating and issued a $32.00 price objective on shares of UiPath in a report on Wednesday, March 20th. Wells Fargo & Company raised their price objective on UiPath from $24.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, March 14th. Finally, Canaccord Genuity Group raised their price objective on UiPath from $27.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, March 15th. Nine analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $27.41.

UiPath Stock Performance

The firm has a fifty day simple moving average of $21.91 and a 200-day simple moving average of $21.65. The company has a market capitalization of $10.98 billion, a PE ratio of -112.88 and a beta of 1.01.

UiPath (NYSE:PATH) last issued its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.10. The company had revenue of $405.25 million during the quarter, compared to analyst estimates of $383.32 million. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. As a group, research analysts anticipate that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Transactions at UiPath

In related news, CFO Ashim Gupta sold 40,000 shares of the business’s stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $21.66, for a total transaction of $866,400.00. Following the completion of the transaction, the chief financial officer now owns 660,762 shares in the company, valued at approximately $14,312,104.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In the last quarter, insiders sold 72,000 shares of company stock worth $1,591,360. 31.03% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Mark Sheptoff Financial Planning LLC acquired a new position in UiPath during the 4th quarter worth $25,000. HighMark Wealth Management LLC acquired a new position in UiPath during the 4th quarter worth $27,000. Cypress Capital Management LLC WY acquired a new position in UiPath during the 4th quarter worth $29,000. GAMMA Investing LLC acquired a new position in UiPath during the 4th quarter worth $36,000. Finally, FNY Investment Advisers LLC bought a new stake in shares of UiPath in the 4th quarter worth $40,000. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.